Log in to your Inderes Free account to see all free content on this page.
Clinical Laserthermia Systems
3.68
SEK
+1.1 %
CLS B
First North Stockholm
Medical Equipment & Services
Health Care
1 following
+1.1%
-4.66%
-32%
-39.36%
-86.16%
-88.35%
-98.32%
-98.83%
-98.51%
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Read moreMarket cap
74.21M SEK
Turnover
263.14K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
21.2.
2025
Annual report '24
16.5.
2025
Interim report Q1'25
15.8.
2025
Interim report Q2'25
ShowingAll content types
CLS carries out a directed issue to guarantors in connection with completed exercise of warrants
CLS receives SEK 22.4 million through the exercise of warrants of series TO 7 B and decides on a directed issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio